Hyperbaric Chambers: Stroke Risk And Recovery

Hyperbaric oxygen therapy (HBOT) is a treatment that involves breathing in pure oxygen in a pressurised chamber. It is used to speed up the healing of wounds that won't heal, carbon monoxide poisoning, gangrene, and infections in which tissues are starved of oxygen. It is also used to treat scuba divers and firefighters with carbon monoxide poisoning.

HBOT is considered to be generally safe, but there are some risks associated with the treatment. In rare cases, it can cause oxygen poisoning, which may lead to seizures, fluid in the lungs, lung failure, or other problems. It is not recommended for people who have recently had ear surgery, a cold or fever, or certain types of lung disease.

There have been some studies that have looked at the effectiveness of HBOT in treating stroke patients. One study found that HBOT treatments improved neuronal activity in patients between six months and three years post-stroke. Another study, which is currently ongoing, is looking at the effects of HBOT on ischemic stroke patients within 48 hours of suffering a stroke.

Hyperbaric oxygen therapy (HBOT) can cause oxygen toxicity seizures, which can lead to strokes

Hyperbaric oxygen therapy (HBOT) is a treatment that involves breathing in pure oxygen in a pressurised chamber. The pressure inside the chamber is raised to between 1.5 and 3 times higher than the normal air pressure, allowing the lungs to gather and absorb more oxygen. This oxygen-rich blood can then be carried throughout the body, infusing injured tissues that need oxygen to heal.

HBOT has been approved by the U.S. Food and Drug Administration (FDA) to treat a number of conditions, including air or gas embolism, decompression sickness, carbon monoxide poisoning, gas gangrene, crush injuries, severe bone and skin infections, and wounds. It is also used to treat scuba divers with decompression sickness and people with carbon monoxide poisoning, including firefighters and miners.

Although HBOT is generally considered safe, there are some risks associated with the treatment. One of these is oxygen toxicity seizures, which occur with a 0.03% incidence and can be triggered when treatment pressure is increased. These seizures can lead to strokes, although until recently, there had been no reported cases of acute ischaemic events (strokes) resulting from HBOT-induced oxygen toxicity seizures.

In one reported case, an 80-year-old male with a history of cerebrovascular accident (CVA) and other health issues underwent HBOT for a non-healing ulcer on his toe. He tolerated the first treatment well, but during the second treatment, he experienced altered mentation and then a tonic-clonic seizure lasting around 90 seconds. Following the seizure, he was taken to the emergency department and the stroke team was activated. A brain MRI showed acute to sub-acute infarcts, and it was concluded that the stroke may have been caused by seizure-induced demand ischaemia.

This case challenges the view that oxygen toxicity seizures in the clinical hyperbaric setting are benign, and raises questions about the acceptable risk threshold for HBOT in patients with multiple risk factors for cerebrovascular accident (CVA). It also highlights the importance of considering risk factors for cerebrovascular disease when determining treatment pressures for HBOT, as reducing pressure can lower the risk of seizures.

HBOT is used to treat carbon monoxide poisoning, which can cause strokes

Carbon monoxide (CO) is a toxic, colourless, and odourless gas formed from the incomplete combustion of carbon-containing substances. It is often found in car or truck exhaust, smoke from fires, and malfunctioning gas appliances. CO poisoning is a medical emergency and can lead to loss of consciousness and death. The first step in treating CO poisoning is to get out of the area where the gas is present and get to the hospital.

While many people with CO poisoning can be revived without hyperbaric oxygen therapy (HBOT), long-term damage can include harm to the central nervous system and the cardiovascular system. HBOT can be used to treat CO poisoning by filling the blood with enough oxygen to repair tissues and restore normal body function. The therapy can cut the risk of brain injury and nerve damage by flooding the body with pure oxygen, which improves oxygenation from the lungs to systemic organs.

Although HBOT is a useful treatment for CO poisoning, it is not without its risks. Oxygen toxicity seizures are a well-known complication of HBOT, and there have been reported cases of acute ischaemic events (strokes) resulting from HBOT-induced oxygen toxicity seizures. Cerebrovascular disease may predispose a person to demand ischaemic insult in the face of oxygen toxicity seizures. Therefore, it is important to consider risk factors for cerebrovascular disease when determining treatment pressures for HBOT.

HBOT is used to treat decompression sickness, which can cause strokes

Hyperbaric oxygen therapy (HBOT) is used to treat decompression sickness, which can cause strokes. Decompression sickness, also known as "the bends", is a condition that can affect divers who ascend too quickly. As a person descends underwater, the pressure on their body increases, causing the air they breathe to be compressed to a smaller volume. This increased pressure means the body takes in more gas molecules with each breath. If a diver ascends too quickly, the excess gas can form bubbles in their blood, blocking blood flow and causing symptoms such as joint pain and fatigue. In severe cases, decompression sickness can lead to strokes.

HBOT is a well-established treatment for decompression sickness. During HBOT, the patient breathes pure oxygen in a pressurised chamber. This therapy increases the amount of oxygen in the blood, helping to repair damaged tissues and restore normal body function. HBOT was first used to treat decompression sickness in the 1940s by the US Navy and is still used today to treat sick scuba divers.

While HBOT is an effective treatment for decompression sickness, it is important to note that it is not without risks. In rare cases, HBOT can lead to oxygen poisoning, which can cause seizures, fluid in the lungs, and lung failure. Therefore, it is crucial to carefully consider the potential benefits and risks of HBOT before starting treatment and to always seek medical advice.

HBOT is used to treat gas gangrene, which can cause strokes

Hyperbaric oxygen therapy (HBOT) is used to treat gas gangrene, which can cause strokes. Gas gangrene is a serious infection caused by gas-forming bacteria, often Clostridium, which contaminates wounds and allows gas to get trapped under the skin, killing body tissue. Symptoms include high fevers, blisters, and continuous inflammation, which can worsen quickly. HBOT is used to treat gas gangrene by keeping swelling down and preventing the infection from spreading to other parts of the body. It does this by flooding the blood with pure oxygen at higher-than-normal atmospheric pressure, which reduces brain swelling and provides crucial nutrients to oxygen-starved brain matter, muscle, and bone.

HBOT has been shown to be effective in treating gas gangrene. A study by Dr. Shai Efrati of Tel Aviv University's Sackler Faculty of Medicine found that high oxygen levels can reinvigorate dormant neurons in stroke patients. The study showed that HBOT treatments improved patients' conditions, including reversing paralysis, increasing sensation, and renewing their ability to use language.

However, it is important to note that HBOT is not always safe and effective for treating certain conditions, such as strokes. While HBOT can be beneficial in treating gas gangrene, which can cause strokes, it is not recommended as a direct treatment for strokes.

HBOT is used to treat acute or traumatic reduced blood flow in the arteries, which can cause strokes

Hyperbaric oxygen therapy (HBOT) is used to treat acute or traumatic reduced blood flow in the arteries, which can cause strokes. HBOT is a medical treatment that involves breathing in pure oxygen in a pressurised chamber. The pressure inside the chamber is raised to between 1.5 and 3 times higher than the normal pressure in the atmosphere. This pressurised environment increases the amount of oxygen that can be carried by the blood, which can help to repair damaged tissue and restore normal body function.

HBOT is used to treat a range of conditions, including acute or traumatic reduced blood flow in the arteries, which can lead to strokes. The treatment works by flooding oxygen-deprived tissue with increased levels of oxygen, promoting cell repair. It also increases the circulation of stem cells, which can target and repair damaged cells. This can help to prevent tissue death and restore normal blood flow.

HBOT has been shown to be particularly effective in treating peripheral artery disease (PAD), which is the most common cause of reduced blood flow in the arteries. PAD is caused by atherosclerosis, a plaque-induced narrowing of the arteries, which can reduce blood supply to the lower extremities and increase the risk of stroke. HBOT can help to reduce inflammation, promote the formation of new blood vessels, and reverse atherosclerosis, enabling the restoration of normal blood flow.

While HBOT is generally considered safe, there are some potential risks and side effects associated with the treatment. These include ear trauma, eye damage, lung collapse, low blood sugar, and sinus problems. In rare cases, HBOT can also lead to oxygen poisoning, which can cause seizures, fluid in the lungs, lung failure, or other serious complications. Therefore, it is important to carefully consider the potential risks and benefits before undergoing HBOT.

Frequently asked questions